Zobrazeno 1 - 10
of 32
pro vyhledávání: '"O I, Afanasieva"'
Autor:
A. Yu. Filatova, E. A. Larina, O. I. Afanasieva, L. N. Ilina, N. V. Radukhina, M. I. Afanasieva, E. A. Klesareva, A. A. Shiryaev, S. K. Kurbanov, E. E. Vlasova, V. P. Vasiliev, Sergey N. Pokrovsky, Tatiana I. Arefieva
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Aim. To assess the level of lipoprotein (a) (Lp(a)) and other lipid profile parameters, the composition of blood leukocytes in patients with focal and diffuse coronary atherosclerosis who underwent coronary artery bypass surgery (CABG), as well as to
Externí odkaz:
https://doaj.org/article/fbaf57ba306e4d07bbd2e68ef7985da5
Autor:
A. Yu. Filatova, O. I. Afanasieva, T. I. Arefieva, E. A. Klesareva, A. V. Tyurina, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To analyze the relationship of blood lipid profile parameters, including the level of lipoprotein(a) (Lp(a)), and the content of circulating CD4+ T-lymphocytes with premature coronary artery disease (CAD).Material and methods. This retrospective
Externí odkaz:
https://doaj.org/article/fb81eab07c2543e0ad6b10afc15b7d60
Publikováno v:
Медицинская иммунология, Vol 22, Iss 6, Pp 1097-1110 (2021)
Previous studies have shown that prolonged professional contact with chemical xenobiotics contributes to sensitization of immune system and development of typical immunopathological processes, i.e., allergies and autoimmune diseases. Origin and sever
Externí odkaz:
https://doaj.org/article/87f3862bcf684b229de21f35bdbfb4fd
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 52-55 (2019)
Statins are currently the main group of lipid-lowering drugs used in clinical practice. However not all patients manage to achieve ‘target’ levels of LDL. A possible cause is statin-induced increase of expression of hepatocyte PCSK9 which regulat
Externí odkaz:
https://doaj.org/article/27a538ed541d470389d43122911aea0c
Autor:
O. I. Afanasieva, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 101-108 (2019)
Lipoprotein(a) (Lp(a)) is a complex supramolecular complex belonging to apoB100 lipoproteins. Lp(a) consists of a particle of similar low-density lipoprotein, in which the apolipoprotein molecule В100 is covalently linked by a disulfide bond with a
Externí odkaz:
https://doaj.org/article/a44f95f1455f4aa4ac91ea5726caa654
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 82-89 (2019)
The lipid hypothesis of atherosclerosis pathogenesis is based on lipid metabolism disorders and, in particular, hypercholesterolemia. The main participants of dyslipidemia are lipoproteins of various classes. Despite the use of modern lipidlowering d
Externí odkaz:
https://doaj.org/article/d9efc5d076aa4d24a6c46227bf40c04e
Autor:
N A Tmoyan, M V Ezhov, O I Afanasieva, E A Klesareva, O A Razova, V V Kukharchuk, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 90, Iss 9, Pp 31-36 (2018)
Aim. Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the stu
Externí odkaz:
https://doaj.org/article/571a6907198c4d418542a6f7288024b5
Autor:
E. A. Klesareva, O. I. Afanasieva, E. V. Kononova, E. A. Utkina, M. V. Ezhov, T. V. Balakhonova, M. I. Afanasieva, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 13-20 (2018)
Aim. To investigate on the relation of lipoproteide(a) (Lpa), subfractions of atherogenic lipoproteides and titers of specific autoantibodies (autoAb) with the presence and severity of carotid arteries (CA) lesion in statin-naïve patients with sever
Externí odkaz:
https://doaj.org/article/6339af9e45814c28a21cc00945ff86f8
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 99-109 (2018)
Development of innovational biotechnological medications based on humanized or completely human monoclonal antibodies or antisense oligonucleotides has opened a novel epoque in lipid disorders treatment. High efficacy of such biological drugs influen
Externí odkaz:
https://doaj.org/article/a0855f2adceb42d480f59256001066b6
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 16, Iss 4, Pp 45-49 (2017)
Aim. To investigate on the relation of lipoproteide (a) (Lpa), subfractions of intermediate density lipoproteides (IDL) and low density lipoproteides (LDL) with the probability of familial hypercholestrolemia diagnosis (FHE).Material and methods. Tot
Externí odkaz:
https://doaj.org/article/bace5234acd34652aec8a2056a8b0632